Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Calcium, Phosphate, Renal Impairment and Coronary Artery Disease in the Cardio-renal Syndrome, The CAPRICORN-CRS Study (CAPRICORN)

This study has been withdrawn prior to enrollment.
(No patients enrolled.)
Sponsor:
Information provided by (Responsible Party):
James L. Januzzi, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT00853541
First received: February 26, 2009
Last updated: September 22, 2015
Last verified: September 2015
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: October 2011
  Estimated Primary Completion Date: October 2010 (Final data collection date for primary outcome measure)